heart transplant CareDx Q4 Revenues Up 64 Percent The company reported $58.6 million in total revenues for the quarter and said testing services revenues rose 73 percent year over year. Heart Transplant Cell-Free DNA Test Enables Earlier Detection of Acute Rejection Than Biopsy Premium The researchers hope that donor-derived cell-free DNA testing to monitor rejection can help relieve racial disparities in heart transplant outcomes. CareDx Preliminary Q4 Revenues Up 63 Percent, Beat Estimates CareDx expects fourth quarter revenues of $58.4 million to $58.6 million, an increase of approximately 63 percent compared to $35.8 million in Q4 2019. CGS Administrators Aligns Medicare Coverage for CareDx AlloSure Tests The company's AlloSure Kidney test received coverage, along with its AlloSure Heart test when used with the firm's AlloMap test. CareDx Q3 Revenues Up 58 Percent The company reported $53.4 million in total revenues for the quarter and said testing services revenues rose 61 percent year over year. Oct 22, 2020 Local Coverage Determinations Roundup: CareDx, Castle Bio, Decipher Biosciences Oct 1, 2020 CareDx Shares Spike as AlloSure Heart Transplant Test Garners Final LCD From Palmetto Apr 30, 2020 CareDx Q1 Revenues Up 48 Percent Apr 9, 2020 CareDx, Stanford Sue TAI Diagnostics for Patent Infringement Feb 27, 2020 CareDx Q4 Revenues Up 52 Percent Jan 22, 2020 Heart Transplant Monitoring Test From TAI Diagnostics Validated in New Study Premium Nov 19, 2019 Upgrades to CareDx's AlloSure Test Enable Earlier Detection of Transplant Rejection Premium Oct 31, 2019 CareDx Q3 Revenues Up 60 Percent Sep 24, 2019 CareDx, NanoString Collaborate to Develop Organ Transplant Rejection Test Aug 22, 2019 CareDx AlloSure Kidney, Heart Tests Garner Palmetto Draft LCD Aug 1, 2019 CareDx Q2 Revenues Up 76 Percent May 9, 2019 CareDx Plans to Launch New Multi-Modal Kidney Transplant Dx, Incorporating Predictive AI Premium May 8, 2019 CareDx Q1 Revenues Up 84 Percent May 3, 2019 Anthem Blue Cross Brings CareDx's AlloMap Heart Transplant Test In Network Apr 25, 2019 CareDx Acquires Transplant Management Firm for $16M in Cash Mar 6, 2019 CareDx Q4 Revenues Increase 88 Percent Feb 25, 2019 CareDx Expands AlloSure Transplant Test to Lung, Starting With Compassionate Use Premium Feb 15, 2019 Jefferies Initiates Coverage of CareDx With Buy Rating Jan 7, 2019 CareDx Preliminary Q4 Revenues Up at Least 85 Percent Nov 8, 2018 CareDx Q3 Revenues Increase 74 Percent Load More Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.